Compugen Ltd. Files Form 6-K with Press Release

Ticker: CGEN · Form: 6-K · Filed: Jul 21, 2025 · CIK: 1119774

Compugen Ltd 6-K Filing Summary
FieldDetail
CompanyCompugen Ltd (CGEN)
Form Type6-K
Filed DateJul 21, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: filing, press-release, sec-filing

TL;DR

Compugen filed a 6-K on 7/21/25 with a press release attached. Check it out.

AI Summary

On July 21, 2025, Compugen Ltd. announced the issuance of a press release, furnished as Exhibit 99.1 to this Form 6-K. The press release is incorporated by reference into the Company's Registration Statement on Form S-8. Compugen Ltd. is a biological products company based in Holon, Israel.

Why It Matters

This filing indicates that Compugen Ltd. has released new information to the public, which could contain updates on its business, research, or financial status.

Risk Assessment

Risk Level: low — This is a routine filing (Form 6-K) to report the issuance of a press release, with no immediate indication of significant new risks or material adverse events.

Key Players & Entities

  • Compugen Ltd. (company) — Registrant
  • July 21, 2025 (date) — Date of press release issuance
  • Exhibit 99.1 (document) — Attached press release
  • Form S-8 (document) — Registration statement
  • Holon, Israel (location) — Company headquarters

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K filing is to report that Compugen Ltd. issued a press release on July 21, 2025, which is furnished as Exhibit 99.1.

When was the press release issued?

The press release was issued on July 21, 2025.

Where is Compugen Ltd. located?

Compugen Ltd.'s principal executive offices are located at 26 Harokmim Street, Holon, Israel.

Is Compugen Ltd. required to file annual reports under Form 20-F or Form 40-F?

Compugen Ltd. indicates it files annual reports under cover of Form 20-F.

What is the SIC code for Compugen Ltd.?

The Standard Industrial Classification (SIC) code for Compugen Ltd. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on July 21, 2025 regarding COMPUGEN LTD (CGEN).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.